FDA Watchers Say Woodcock Is ‘Excellent Choice’ For Acting Chief

FDA watchers on Thursday (Jan. 14) applauded reports that FDA drug center director Janet Woodcock will serve as acting agency chief until the incoming Biden administration names a permanent commissioner. Woodcock will hit the ground running and give the Biden administration time to find a permanent chief, they say. Earlier this year, Woodcock recused herself from FDA COVID-19 product decisions as she moved to the Office of the Commissioner and took on the role of therapeutics lead with Operation Warp...